These circumstances can imply that there is some degree of interaction between the molecular entities that each gene encodes – as is well established in the case of LDLR and PCSK9 in relation to regulation of circulating low-density lipoprotein cholesterol and, hence, CAD risk33. The gene discussed is LDLR; the disease is coronary artery disorder.